Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peritoneal tissue concentrations of linezolid and tigecycline in surgical ICU patients with peritonitis
2012-000391-42Phase 4Completed
- Sponsor
- Martin Luther University Halle-Wittenberg
- Start
- Apr 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of linezolid and tigecycline in peritonitis and bacterial disease (2 arms), sponsored by Martin Luther University Halle-Wittenberg. Primary endpoint: IMPs plasma and microdialysate concentrations. Started Apr 2012; status: completed.
02
Drugs
linezolidtigecycline
03
Conditions
peritonitisbacterial disease
Beyond the preview
Go deeper on 2012-000391-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000391-42.